LIDOCAINE HCl AND EPI is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Epinephrine Bitartrate; Lidocaine Hydrochloride Anhydrous.
| Product ID | 51662-1589_e52110a0-d181-53a1-e053-2995a90ae9b1 |
| NDC | 51662-1589 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LIDOCAINE HCl AND EPI |
| Generic Name | Lidocaine Hcl And Epi |
| Dosage Form | Injection, Solution |
| Route of Administration | INFILTRATION; PERINEURAL |
| Marketing Start Date | 2022-07-31 |
| Marketing Category | NDA / |
| Application Number | NDA006488 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Active Ingredient Strength | 0 mg/mL; mg/mL |
| Pharm Classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-07-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |